Mkts

Vivos Therapeutics, Inc.

NASDAQ: VVOS
$0.09-0.01 (-8.67%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
0.090.11
52-week range
0.092.72
Today
Open0.10
Previous close0.09
Volume151.5K
Valuation
Market cap3.07M
P/E ratio—
EPS (TTM)-1.88
Income & risk
Dividend / yield—
Beta6.55
Avg volume10.76M
Discussion

VVOS News

Stories mentioning VVOS from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue5,1413,8246,7833,8203,0163,6983,8604,054
Cost of Goods Sold
Gross Profit3,0592,9863,9372,1101,5092,0972,3342,651
Operating Expenses
Research & Development
Sales General & Admin
Total Operating Expenses9,6749,3638,6716,9755,4274,9024,9794,587
Operating Income (Loss)(6,615)(6,377)(4,734)(4,865)(3,918)(2,805)(2,645)(1,936)
Interest Income
Interest Expense1,100500.00
Other Expense(1,167)(635.00)(679.00)(163.00)(4.00)(69.00)(18.00)(22.00)
Pretax Income(7,751)(6,953)(5,400)(5,013)(3,864)(2,827)(2,616)(1,930)
Tax Provision
Net Income (Loss)(7,682)(6,893)(5,400)(5,013)(3,864)(2,827)(2,616)(1,930)
Earnings Per Share (Basic)(0.52)(0.67)(0.49)(0.55)(0.45)(0.56)(0.40)(0.60)
Earnings Per Share (Diluted)(0.52)(0.67)(0.49)(0.55)(0.45)(0.56)(0.40)(0.60)
Weighted Average Shares Outstanding (Basic)14,63410,27410,9649,0878,5955,0206,6153,228
Weighted Average Shares Outstanding (Diluted)14,63410,27410,9649,0878,5955,0206,6153,228

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About VVOS

Vivos Therapeutics, Inc. (NASDAQ: VVOS) is a stock listed on the Nasdaq Stock Market under the ticker symbol VVOS. It last traded at $0.0900 (Nov 6, 2026, 4:00 PM ET), down 8.7% on the day. That gives Vivos Therapeutics a market capitalisation of $3.1M.

Over the past 52 weeks VVOS has traded between $0.0900 and $2.72.

Revenue for the quarter ended Mar 31, 2026 was $5.1M; a net loss of $7.7M. Revenue was up 70.5% from $3.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$5.1M-$7.7M-149.4%
Dec 31, 2025$3.8M-$6.9M-180.3%
Sep 30, 2025$6.8M-$5.4M-79.6%
Jun 30, 2025$3.8M-$5.0M-131.2%

From Vivos Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…